Emerging Treatment Strategies in Peripheral Artery Disease (PAD)

Description

This activity is part of the Peripheral Artery Disease: Optimizing Treatment Strategies grant.

Accreditation Statement

In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page.

Joint Accreditation

In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement
Physicians

The ACCF designates this online enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

While offering the CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Nurses
The ACCF designates this educational activity for a maximum of 0.50 continuing nursing education contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.

MOC Information

Successful completion of this certified activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Target Audience:

This activity is intended for cardiovascular physicians, registered nurses, and pharmacists.   

Important Dates:
Date of Release: February 23, 2022
Term of Approval/Date of Expiration: February 23, 2023

Learner Objectives:
Upon completion of this activity, you should be able to:

Develop a PAD treatment plan including GDMT as well as emerging therapeutics.

Acknowledgements:
Supported by an educational grant from: Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC

Faculty:

Naomi M. Hamburg, MD, FACC
Connie N. Hess, MD, FACC

Reviewers:
Aaron W. Aday, MD
Marc P. Bonaca, MD, FACC

Summary


Availability:	On-Demand
	Expires on Jun 09, 2025


Cost:	FREE


Credit Offered:	0.5 CME Credit 0.5 CNE Credit 0.5 ABIM-MOC Point